1. Home
  2. MITQ vs BRTX Comparison

MITQ vs BRTX Comparison

Compare MITQ & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moving iMage Technologies Inc.

MITQ

Moving iMage Technologies Inc.

N/A

Current Price

$0.62

Market Cap

5.4M

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

N/A

Current Price

$0.20

Market Cap

5.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MITQ
BRTX
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Managed Health Care
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4M
5.4M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
MITQ
BRTX
Price
$0.62
$0.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.2K
193.2K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,139,000.00
$81,000.00
Revenue This Year
N/A
$298.39
Revenue Next Year
N/A
$64.62
P/E Ratio
$58.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$0.16
52 Week High
$1.66
$1.73

Technical Indicators

Market Signals
Indicator
MITQ
BRTX
Relative Strength Index (RSI) 51.94 33.63
Support Level $0.56 $0.19
Resistance Level $0.57 $0.24
Average True Range (ATR) 0.03 0.02
MACD 0.01 0.00
Stochastic Oscillator 45.72 6.11

Price Performance

Historical Comparison
MITQ
BRTX

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: